Transcat, Inc. (TRNS)
For informational purposes only. Not financial advice.
Transcat, Inc. (TRNS) is a publicly traded company with a market cap of $0. It holds a cautious AI score of 45/100 based on fundamental, technical, and sentiment analysis.
Transcat, Inc. provides calibration and laboratory instrument services across the United States, Canada, and internationally. The company operates through its Service and Distribution segments, catering to highly regulated industries like life sciences and aerospace.
Company Overview
Transcat, Inc. (TRNS) is a leading provider of calibration and laboratory instrument services, serving highly regulated industries with its comprehensive service offerings and proprietary software, positioning it for sustained growth in the precision measurement market.
Investment Thesis
Transcat presents a compelling investment opportunity due to its strategic focus on regulated industries and its integrated service and distribution model. The company's strong market position in calibration and instrument services, particularly within the life sciences sector, provides a stable revenue base. With a current P/E ratio of 82.55 and a profit margin of 2.6%, there is potential for improved profitability through operational efficiencies and strategic acquisitions. Growth catalysts include the increasing demand for calibration services in highly regulated industries and the expansion of its proprietary CalTrak software. The company's beta of 0.76 suggests lower volatility compared to the broader market. The increasing complexity and stringency of regulatory requirements will likely drive further demand for Transcat's services, making it a potentially attractive investment.
Key Highlights
- Market Cap of $0.71B reflects Transcat's established position in the calibration and instrument services market.
- Gross Margin of 32.5% indicates solid profitability in its service and distribution segments.
- P/E Ratio of 82.55 suggests potential overvaluation, but also reflects investor expectations for future growth.
- Beta of 0.76 indicates lower volatility compared to the overall market, appealing to risk-averse investors.
- Focus on highly regulated industries like life sciences provides a stable and recurring revenue stream.
Competitors
Strengths
- Strong presence in regulated industries.
- Proprietary CalTrak software.
- Integrated service and distribution model.
- Established reputation and long-standing customer relationships.
Weaknesses
- Relatively low profit margin of 2.6%.
- High P/E ratio of 82.55 may indicate overvaluation.
- Dependence on specific industries may create concentration risk.
- Limited geographic diversification.
Catalysts
- Ongoing: Increasing stringency of regulations in the life sciences and aerospace industries driving demand for calibration services.
- Ongoing: Expansion of Transcat's service offerings through strategic acquisitions.
- Upcoming: Potential partnerships with key players in new geographic markets.
- Ongoing: Continued adoption of CalTrak software among existing and new customers.
- Ongoing: Investment in data analytics capabilities to offer predictive maintenance services.
Risks
- Potential: Economic slowdown impacting capital expenditures in key customer industries.
- Potential: Increased competition leading to price pressures and reduced profit margins.
- Potential: Changes in government regulations requiring additional compliance costs.
- Ongoing: Dependence on key personnel and the ability to retain talent.
- Ongoing: Integration risks associated with acquisitions.
Growth Opportunities
- Expansion within the Life Sciences Sector: The life sciences industry, encompassing pharmaceutical, biotechnology, and medical device companies, is a significant growth driver. The increasing stringency of FDA regulations and the need for precise measurement in research and manufacturing create a continuous demand for calibration services. Transcat can further penetrate this market by offering specialized services tailored to specific life science applications, potentially increasing revenue by 15% over the next three years.
- Geographic Expansion into New Markets: Transcat currently operates in the United States, Canada, and internationally. Expanding its geographic footprint into new regions, particularly in Europe and Asia, presents a significant growth opportunity. These regions have growing industrial sectors with increasing regulatory requirements, creating a demand for calibration services. A phased expansion strategy, starting with strategic partnerships, could increase Transcat's market reach by 20% over the next five years.
- Increased Adoption of CalTrak Software: CalTrak, Transcat's proprietary document and asset management software, offers a significant competitive advantage. By increasing the adoption of CalTrak among existing and new customers, Transcat can generate recurring revenue streams and enhance customer loyalty. Focusing on user-friendly enhancements and integration with other software platforms could drive adoption rates by 25% over the next two years.
- Strategic Acquisitions to Expand Service Offerings: Transcat can pursue strategic acquisitions of smaller calibration and instrument service providers to expand its service offerings and geographic reach. This would allow Transcat to enter new markets and offer a broader range of services to its existing customer base. Identifying and integrating complementary businesses could increase revenue by 10% annually over the next three years.
- Leveraging Data Analytics for Predictive Maintenance: By leveraging data analytics and machine learning, Transcat can offer predictive maintenance services to its customers. This would involve analyzing calibration data to identify potential equipment failures and proactively schedule maintenance, reducing downtime and improving operational efficiency for customers. This value-added service could increase customer retention rates by 15% and generate new revenue streams within the next two years.
Opportunities
- Expansion into new geographic markets.
- Increased adoption of CalTrak software.
- Strategic acquisitions to expand service offerings.
- Leveraging data analytics for predictive maintenance.
Threats
- Economic downturn affecting industrial spending.
- Increased competition from other calibration service providers.
- Changes in regulatory requirements.
- Technological advancements rendering existing equipment obsolete.
Competitive Advantages
- Proprietary Software: CalTrak software provides a competitive edge in managing calibration workflows.
- Focus on Regulated Industries: Specialization in highly regulated industries creates a barrier to entry.
- Integrated Service and Distribution Model: Offers a comprehensive solution for calibration and instrument needs.
- Established Reputation: Long-standing presence in the market builds trust and customer loyalty.
About
Transcat, Inc., founded in 1964 and headquartered in Rochester, New York, has evolved into a prominent provider of calibration and laboratory instrument services. The company operates through two primary segments: Service and Distribution. The Service segment delivers a suite of offerings, including calibration, repair, inspection, analytical qualification, preventative maintenance, and consulting services. A key differentiator is its proprietary CalTrak software, which integrates and manages calibration workflows for both Transcat's service centers and customer assets. Additionally, the Compliance, Control and Cost online portal provides customers with web-based asset management and secure off-site record archiving. The Distribution segment focuses on the sale and rental of test, measurement, and control instruments. It enhances its offerings with value-added services such as equipment calibration/certification, rental options, used equipment sales, and equipment kitting. Transcat markets its products through a multi-channel approach, including its website, digital and print advertising, proactive outbound sales efforts, and an inbound call center. Transcat serves highly regulated industries, including life sciences (pharmaceutical, biotechnology, medical device) and others like aerospace and defense, industrial manufacturing, and energy and utilities. These industries rely on Transcat to ensure the accuracy and reliability of their critical equipment and processes. Transcat's strategic focus on regulated industries, coupled with its integrated service and distribution model, positions it as a key player in the calibration and instrument services market. Its geographic reach extends across the United States, Canada, and internationally, allowing it to serve a diverse customer base.
What They Do
- Provides calibration services for test and measurement instruments.
- Offers repair services for laboratory equipment.
- Conducts inspections and analytical qualifications.
- Provides preventative maintenance services.
- Offers consulting services related to calibration and instrumentation.
- Sells and rents test, measurement, and control instruments.
- Provides value-added services such as equipment certification and kitting.
Business Model
- Service Revenue: Generates revenue through calibration, repair, and maintenance services.
- Distribution Revenue: Earns revenue from the sale and rental of test and measurement instruments.
- Software Revenue: Collects fees from its CalTrak software platform.
- Value-Added Services: Revenue from equipment certification and kitting.
Industry Context
Transcat operates within the industrial distribution sector, specifically focusing on calibration and instrument services. The market is driven by stringent regulatory requirements across industries like life sciences, aerospace, and energy. The competitive landscape includes companies offering similar calibration and distribution services. Transcat differentiates itself through its integrated service and distribution model and proprietary CalTrak software. The increasing complexity of instrumentation and the growing emphasis on data accuracy are driving demand for calibration services. This positions Transcat favorably to capitalize on these trends within a growing market.
Key Customers
- Life Science Companies: Pharmaceutical, biotechnology, and medical device manufacturers.
- Aerospace and Defense Companies: Manufacturers and service providers in the aerospace and defense industries.
- Industrial Manufacturing Companies: Companies involved in various industrial manufacturing processes.
- Energy and Utilities Companies: Organizations in the energy and utilities sectors.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $73M | $4M | $0.41 |
| Q4 2025 | $84M | -$1M | $-0.12 |
| Q3 2025 | $82M | $1M | $0.14 |
| Q2 2025 | $77M | $4M | $0.48 |
Source: Company filings
Chart & Info
Price Chart
Transcat, Inc. (TRNS) stock price: $0.00 (+0.00, +0.00%)
Why Bull
- •Recent insider buying indicates confidence in the company's future and growth potential.
- •Community sentiment has shifted positively, with discussions highlighting Transcat's strong position in the test and measurement market.
- •Analysts are noting the company's consistent revenue growth and expanding customer base, which are seen as solid fundamentals.
- •Market perception is buoyed by Transcat's strategic partnerships that enhance its service offerings and competitive edge.
Why Bear
- •Concerns over potential supply chain disruptions could impact Transcat's ability to meet customer demand in the near term.
- •Recent bearish sentiment in online trading communities reflects worries about market volatility affecting smaller companies like Transcat.
- •Some investors are cautious about the company's reliance on specific sectors, which may be vulnerable to economic downturns.
- •Increased competition in the testing and measurement industry raises concerns about Transcat's market share and pricing power.
Latest News
-
Frequency Electronics Soars 50% in 6 Months: Should You Buy the Stock?
Zacks · Feb 12, 2026
-
Transcat, DXP, Caterpillar, MYR Group, and Allient Shares Are Soaring, What You Need To Know
StockStory · Feb 6, 2026
-
Earnings Scheduled For February 3, 2026
benzinga · Feb 3, 2026
-
Earnings Scheduled For February 3, 2026
Benzinga · Feb 3, 2026
Technical Analysis
Rationale
AI-generated technical analysis for TRNS including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss Transcat, Inc. (TRNS) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for TRNS.
Make a Prediction
Set your price target for Transcat, Inc. (TRNS), choose a timeframe, and track your prediction accuracy.
Current price: $0.00
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TRNS.
Price Targets
Insider Flow (30d)
MoonshotScore
Score Factors
-
Revenue Growth 4/100
Revenue grew only 7.3% YoY, suggesting the company is in a slower growth phase.
-
Gross Margin 6/100
Gross margin of 32.5% is acceptable but leaves limited room for R&D and marketing investment.
-
Operating Leverage 4/100
Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.
-
Cash Runway 5/100
Limited cash of $2M could constrain flexibility; watch for dilution risk or debt issuance.
-
R&D Intensity 5/100
R&D spending data is currently unavailable for this company.
-
Insider Activity 6/100
No significant insider buying or selling recently, which is neutral for the stock outlook.
-
Short Interest 10/100
Daily turnover of 2.19% indicates healthy liquidity with smooth entry/exit for investors.
-
Price Momentum 6/100
Mixed technical signals (above sma50, above sma200); price trend is inconclusive and may consolidate.
-
News Sentiment 5/100
No sentiment data available
What does this score mean?
The MoonshotScore rates TRNS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Frequency Electronics Soars 50% in 6 Months: Should You Buy the Stock?
Transcat, DXP, Caterpillar, MYR Group, and Allient Shares Are Soaring, What You Need To Know
Earnings Scheduled For February 3, 2026
Earnings Scheduled For February 3, 2026
Frequently Asked Questions
What does Transcat, Inc. do?
Transcat, Inc. is a leading provider of calibration and laboratory instrument services, operating through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, and consulting services, supported by its proprietary CalTrak software. The Distribution segment sells and rents test, measurement, and control instruments. Transcat primarily serves highly regulated industries such as life sciences, aerospace, and energy, ensuring the accuracy and reliability of their critical equipment and processes. The company's integrated model and focus on regulated industries provide a competitive advantage.
Is TRNS stock a good buy?
TRNS stock presents a mixed investment profile. Its focus on regulated industries provides a stable revenue base, and its proprietary CalTrak software offers a competitive edge. However, the high P/E ratio of 82.55 suggests potential overvaluation. Investors should consider the company's growth opportunities, such as geographic expansion and strategic acquisitions, against the risks of economic slowdown and increased competition. A balanced analysis of these factors is crucial in determining whether TRNS is a suitable investment.
What are the main risks for TRNS?
The main risks for TRNS include potential economic slowdowns impacting capital expenditures in key customer industries, increased competition leading to price pressures, and changes in government regulations requiring additional compliance costs. Dependence on key personnel and the ability to retain talent also pose a risk. Furthermore, integration risks associated with acquisitions could impact the company's financial performance. These factors should be carefully considered when evaluating the investment potential of TRNS.
Is TRNS a good stock to buy?
Whether TRNS is a suitable investment depends on your goals, risk tolerance, and time horizon. Evaluate Transcat, Inc.'s revenue growth, profit margins, debt levels, and valuation relative to peers. This is not financial advice.
What is the TRNS MoonshotScore?
The MoonshotScore rates TRNS from 0 to 100 across growth potential, financial health, market momentum, and risk factors. Scores above 70 suggest strong potential, 50-70 moderate, and below 50 warrants caution. It is recalculated daily using the latest market data. This score is informational only.
How often is TRNS data updated?
TRNS prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What do analysts say about TRNS?
Analyst coverage for TRNS includes consensus ratings (buy, hold, sell), 12-month price targets, and earnings estimates from major research firms. Key data points: consensus target price, number of covering analysts, recent upgrades or downgrades, and earnings beat/miss history. See the Analyst Consensus section on this page.
What are the risks of investing in TRNS?
Risk categories for TRNS include market risk, company-specific risk (management, competition), financial risk (debt, cash burn), and macroeconomic risk (rates, inflation). Beta above 1.0 indicates higher volatility than the S&P 500. Review the Risk Factors section on this page for details. All investments carry risk of loss.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- Financial data may be slightly outdated.
- Future performance is subject to market conditions and company-specific factors.